Quick Facts at a Glance
- Recall Date
- October 9, 2025
- Hazard Level
- HIGH
- Brand
- STAQ Pharma
- Category
- Health & Personal Care
- Sold At
- Multiple Retailers
- Geographic Scope
- 1 states
- At-Risk Groups
- GENERAL
What to Do Now
Use this page like a recall checklist: verify the product first, then act on the official remedy.
Immediate steps
- 1Stop using the product until you confirm whether it is included in the recall.
- 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
- 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
- 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.
Check these identifiers
- Brand
- STAQ Pharma
- Product type
- Intravenous Hydromorphone Injection
- Model numbers
- 25104595A, Expiry 27DEC2025
- Sold at
- Multiple Retailers
- Where affected
- ALL
Recall Timeline
Key dates and source checks for this recall record.
Recall announced
October 9, 2025
Reported by FDA DRUG
October 22, 2025
RecallRadar source check
April 18, 2026
Consumer action
Use the official remedy and keep documentation.
Hazard Information
Labeling: Incorrect or Missing Lot and/or Exp Date
What You Should Do
Consumers and healthcare providers should stop using this product immediately. Contact STAQ Pharma, Inc. or your healthcare provider for guidance. Notification method: Letter
About This Product
Hydromorphone HCl PF is a prescription opioid analgesic prepared for intravenous use in medical settings. Correct lot and expiry labeling is essential for patient safety.
Why This Is Dangerous
Incorrect or missing lot and expiry data can lead to incorrect identification or administration of expired product, posing patient safety risks.
Industry Context
This recall is not presented as part of a broader industry pattern.
Real-World Impact
Hospitals and clinics must verify labeling before use; patients could experience treatment delays or dosing errors during recall replacements.
Practical Guidance
How to identify if yours is affected
- Locate the product label for Lot 25104595A and Expiry 27DEC2025
- Cross-check NDC 73177-0104-05 on the packaging
- Review inventory logs for recent distributions of this lot
Where to find product info
Label on syringe packaging and accompanying documentation; NDC on the label
What timeline to expect
Not specified; follow STAQ Pharma recall communications for remediation timelines
If the manufacturer is unresponsive
- Document all attempts to contact STAQ Pharma
- Coordinate with hospital recalls office or pharmacists
- File a recall complaint with FDA if necessary
How to prevent similar issues
- Implement double-checks for lot/expiry during receiving and administration
- Use electronic inventory controls with expiry warnings
- Regularly review FDA recall notices for drug labeling issues
Documentation advice
Keep copy of recall notice, lot and expiry records, and all correspondence with STAQ Pharma
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
Product Details
Model numbers/identifiers: Lot 25104595A; Expiry 27DEC2025. Sold nationwide through medical facilities and distributors. NDC 73177-0104-05. Manufacturer: STAQ Pharma, Inc., 14135 E 42nd Ave, Denver, CO.
Reported Incidents
No injuries or incidents have been reported.
Key Facts
- Hydromorphone HCl PF, 10mg/50mL in saline for IV use
- Nationwide U.S. distribution
- Active recall as of 2025-10-22
Browse More Recalls
Safety Guide
Not sure what to do next? Our guide walks you through the process step by step.
Read: What to Do When You Find a Recalled ProductGet Alerts for Health & Personal Care Recalls
Get instant alerts for recalls that affect you. Free forever.
